Results

Total Results: over 10,000 records

Showing results for "drugs".

  1. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
    January 01, 2009 - and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
  2. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
    January 01, 2009 - and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
  3. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
    January 01, 2009 - and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
  4. www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
    January 01, 2009 - and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
  5. effectivehealthcare.ahrq.gov/sites/default/files/searching.ppt
    January 01, 2011 - Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. … or may be incompletely published elsewhere Good check for publication bias Regulatory Web sites: Drugs … That is because the approval process for new drugs and devices requires submission of data that may not … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. Sassi F, Archard L, McDaid D. 
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/searching.ppt
    January 01, 2011 - Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. … or may be incompletely published elsewhere Good check for publication bias Regulatory Web sites: Drugs … That is because the approval process for new drugs and devices requires submission of data that may not … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. Sassi F, Archard L, McDaid D. 
  7. www.ahrq.gov/research/findings/studies/index.html?page=238
    January 01, 2024 - monitoring (PDMP) programs, which constitute a key policy targeting access to non-medical use of Rx drugs
  8. psnet.ahrq.gov/issue/effort-human-factors-performance-and-decision-making
    August 31, 2022 - Commentary Effort in human factors performance and decision making. Citation Text: Wickens CD. Effort in human factors performance and decision making. Hum Factors. 2014;56(8):1329-36. Copy Citation Format: Google Scholar PubMed BibTeX EndNote X3 XML EndNote 7 XML Endnote t…
  9. psnet.ahrq.gov/issue/individual-based-framework-study-medical-error
    November 11, 2020 - Commentary An individual-based framework for the study of medical error. Citation Text: Veazie PJ. An individual-based framework for the study of medical error. Int J Qual Health Care. 2006;18(4):314-9. Copy Citation Format: Google Scholar PubMed BibTeX EndNote X3 XML End…
  10. psnet.ahrq.gov/issue/resistance-patient-safety-initiatives
    November 26, 2014 - Newspaper/Magazine Article Resistance to patient safety initiatives. Citation Text: O'Connor EJ, Fiol M. Resistance to patient safety initiatives. Physician executive. 2005;31(6):64-7. Copy Citation Format: Google Scholar PubMed BibTeX EndNote X3 XML EndNote 7 XML Endnote…
  11. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/50929/psn-pdf
    February 26, 2020 - Discharged with IV antibiotics: When issues arise, who manages the complications? February 26, 2020 Donnelley M, Gintjee TJ, Go J. Discharged with IV antibiotics: When issues arise, who manages the complications? PSNet [internet]. 2020. https://psnet.ahrq.gov/web-mm/discharged-iv-antibiotics-when-issues-arise-who-…
  12. psnet.ahrq.gov/web-mm/discharge-fumbles
    September 09, 2009 - addition, his commentary does not include information regarding investigational or off-label use of pharmaceuticalproducts or medical devices.
  13. psnet.ahrq.gov/web-mm/wrong-shot-error-disclosure
    May 01, 2011 - addition, their commentary does not include information regarding investigational or off-label use of pharmaceuticalproducts or medical devices.
  14. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49450/psn-pdf
    June 01, 2004 - addition, their commentary does not include information regarding investigational or off-label use of pharmaceuticalproducts or medical devices.
  15. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-1.pdf
    March 01, 2022 - Results from included studies: KQ 2. nonsteroidal anti-inflammatory drugs ............ … Rimegepant 75 mg is more effective for migraine than nonsteroidal anti-inflammatory drugs: post hoc … Biohaven Pharmaceuticals I. … Biohaven Pharmaceuticals I. … CNS Drugs. 2020 Oct;34(10):1015-24. doi: 10.1007/s40263-020- 00753-1. PMID: 32857291.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
    June 01, 2022 - Results from included studies: KQ 2. nonsteroidal anti-inflammatory drugs ............ … Rimegepant 75 mg is more effective for migraine than nonsteroidal anti-inflammatory drugs: post hoc … Biohaven Pharmaceuticals I. … Biohaven Pharmaceuticals I. … CNS Drugs. 2020 Oct;34(10):1015-24. doi: 10.1007/s40263-020- 00753-1. PMID: 32857291.
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
    June 01, 2022 - Results from included studies: KQ 2. nonsteroidal anti-inflammatory drugs ............ … Rimegepant 75 mg is more effective for migraine than nonsteroidal anti-inflammatory drugs: post hoc … Biohaven Pharmaceuticals I. … Biohaven Pharmaceuticals I. … CNS Drugs. 2020 Oct;34(10):1015-24. doi: 10.1007/s40263-020- 00753-1. PMID: 32857291.
  18. www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZTMgupsEkCUuuPVpeGUm45
    September 01, 2013 - Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement Virginia A. Moyer, MD, MPH, on behalf of the U.S. Preventive Services Task Force* Description: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for and treatment …
  19. effectivehealthcare-admin.ahrq.gov/products/colorectal-cancer-liver-metastases-therapies/research-protocol
    December 01, 2019 - whereby the concentration of a drug is greatly reduced before it reaches the systemic circulation) of drugs … Chemoembolization drugs and embolic mixtures have also changed a great deal in the last ten years and
  20. www.qualitymeasures.ahrq.gov/patient-safety/quality-measures/21st-century/index.html
    June 01, 2018 - found that antibiotics are frequently over-prescribed, contributing to microbial resistance to these drugs